Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Recipe For Doubling Innovative Medicines Includes New Approval Pathway, FDA Management Changes

Executive Summary

Presidential advisory panel makes eight recommendations to improve innovation in drug discovery, development and evaluation; calls for broad partnership of stakeholders to accelerate therapeutics, $40 million annual appropriations for FDA’s Sentinel System.

You may also be interested in...

Antibiotic Development To Get Fresh Push, Not Fresh Ideas, From PCAST

Upcoming report from presidential advisors will endorse limited population approval, and government funding mechanisms as part of plan to fight resistance.

FDA, Uninvited To Congress’ PCAST Hearing, Blogs Its Accomplishments

Woodcock says “critical challenges” remain on implementing recommendations of President’s Council, but timing of statement could be signal to Congress: be careful what else you put on our plates.

Lagging CDER Review Divisions Could Learn From Oncology, Antiviral Offices

FDA’s drugs center should identify “best practices” in oncology and antiviral drug reviews that could be applied by less efficient review divisions, such as cardio/renal and neurology, authors of a Manhattan Institute report say.

Related Content


Related Companies

Latest News
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts